Alberta Innovates’ Accelerating Innovations into CarE (AICE) suite of programs provide a coordinated series of enabling mechanisms to support innovators along their health technology commercialization journey from ideation to leading. Below you will find a list of current projects supported under the AICE programs.
Accelerating Innovations into CarE (AICE) – Concepts Program
The Accelerating Innovations into CarE (AICE) – Concepts Program serves to advance early-stage health research that demonstrates high commercial potential in priority areas of precision health. AICE-Concepts enables innovators to accelerate their journey across four domains of commercialization: Product development, business readiness, product-market fit, and regulatory compliance.
2023 Investments
The table below contains investment results for five Alberta-based researchers and one Alberta-based small-medium enterprise. Total value for all six projects is ~$4.5 million with ~$3 million contributed from Alberta Innovates. Projects will run from February 2023 to January 2026.
Lead Applicant | AICE Stream | Project Title | Contact | Award Amount |
Amin Komeili, PhD, UCalgary |
AICE-Concepts | A Data Driven Human Assistive Device for Knee Rehabilitation | Website | $511,000 |
Edmond Lou, PhD, UAlberta | AICE-Concepts | Applying Artificial Intelligence on Ultrasound and Surface Topography Images Combined with Spinal Bone Quality to Predict Progression of Scoliosis | Website | $586,000 |
Larry Unsworth, PhD, UAlberta | AICE-Concepts | Developing diagnostic and prognostic clinical tools for chronic kidney disease patients | Website | $599,618 |
Manisha Gupta, PhD, UAlberta | AICE-Concepts | Biosensor development for detection and monitoring of neurological conditions in diabetic patients | Website | $600,000 |
Peter Stys, MD, UCalgary | AICE-Concepts | Machine-Learning-Assisted Spectroscopic Fluorescence Urinalysis for Intelligent Diagnosis of Misfolded Protein Disorders | Website | $598,000 |
OKAKI Health Intelligence Inc. Salim Samanani, MD |
AICE-Concepts | GAITLY – Deep learning-based gait and balance assessment application | Website | $200,000 |
2022 Investments
The table below contains information about the eight leading Alberta-based researchers and their projects. Total value for all eight projects is nearly $7.5 million with ~ $4.5 million contributed from Alberta Innovates. Projects will run from February 2022 to January 2025.
Lead Applicant | AICE Stream | Project Title | Contact | Award Amount |
Aravind Ganesh, MD, UCalgary |
AICE-Concepts | Automated Remote Image-guided Diagnosis and Risk Stratification of Carotid Disease for Stroke prevention
|
Website | $600,000 |
Jacob Jaremko, MD, PhD, UAlberta |
AICE-Concepts | Basic echo: point-of-care ultrasound assessment of cardiac function using artificial intelligence
|
Website | $591,000 |
John Lewis, PhD, UAlberta | AICE-Concepts | An Integrated Extracellular Vesicle Biomarker and Machine Learning Approach to Diagnosing Bladder Cancer
|
Website | $600,000 |
Joon Lee, PhD, UCalgary |
AICE-Concepts | Leveraging Artificial Intelligence and the APPROACH Registry to Transform Coronary Artery Disease Patient Care
|
Website | $600,000 |
Kara Nerenberg, MD, UCalgary | AICE-Concepts | IMPROVE-Virtual HEALTH (Healthy Eating and Active Living through Technology @ Home) For MOMS
|
Website | $572,185 |
Lawrence Le, PhD, UAlberta | AICE-Concepts | Intraoral Ultrasound Fusion of Dento-Periodontal Complex for Diagnosis of Periodontal Diseases and Personalized Treatment
|
Website | $600,000 |
Puneeta Tandon, MD, UAlberta |
AICE-Concepts | The creation of a home-based digital solution to diagnose functional decline and inform tailored lifestyle prescriptions for patients with catabolism-prone chronic diseases
|
Website | $598,394 |
Richard Fahlman, PhD, UAlberta |
AICE-Concepts | Rapid Testing for Myasthenia Gravis
|
Website | $340,855 |
View our 2021 investments
Accelerating Innovations into CarE (AICE) – Market Access Program
The Accelerating Innovations into CarE (AICE) – Market Access Program accelerates health innovations that face evidentiary hurdles in achieving market access. The Program supports small-to-medium-sized enterprises (SMEs) and real-world testing sites (Testing Sites) in carrying out clinical trials, feasibility studies or real-world trials to fast-track commercial progression and market adoption.